Skip to main content
. 2015 Jul 8;2015:421624. doi: 10.1155/2015/421624

Figure 8.

Figure 8

Inflammatory status in MECP2- and CDKL5-mutated Rett patients before and after ω-3 PUFAs supplementation. Data are expressed as means ± standard deviations. Asterisks denote significant post hoc pairwise tests (P < 0.05). The dashed line denotes upper range limit as obtained from clinical laboratory.